DB
QTTB icon

Danske Bank’s Q32 Bio QTTB Stock Holding History

Danske Bank’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Hold
1
– – ﹤0.01% 1098
2025
Q4 		$3 Hold
1
– – ﹤0.01% 1530
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1474
2025
Q2 		$1 Hold
1
– – ﹤0.01% 1523
2025
Q1 		$2 Hold
1
– – ﹤0.01% 1349
2024
Q4 		$3 Hold
1
– – ﹤0.01% 1372
2024
Q3 		$45 Buy
+1
New +$37 ﹤0.01% 1478

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Danske Bank's QTTB Position: Q1 2026 in Review

Danske Bank held its Q32 Bio (QTTB) position steady in Q1 2026 at 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Danske Bank first reported a position in QTTB in Q3 2024 and has held it in 7 quarters since. The position peaked at $45 in Q3 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Danske Bank held 1 share of Q32 Bio worth $6 as of Q1 2026.
  • Danske Bank left its Q32 Bio share count unchanged in Q1 2026.
  • Q32 Bio made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1098 holding.
  • Danske Bank first reported a position in Q32 Bio in Q3 2024 and has held it in 7 quarters since.
  • Danske Bank's Q32 Bio position peaked at $45 in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.